Atlas Trials

Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC

Clinical trial NCT00319800 · UNKNOWN

Trial details

NCT number
NCT00319800
Sponsor
Gachon University Gil Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer
Start date
2006-02-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.